Qualmedica Research and WKH&L Research Foundation are working together to offer cutting edge therapies to patients at Med Center Health. Qualmedica Research is a multi-site clinical research company offering access to clinical trials in Kentucky and Indiana, USA. Our mission is to enable better health for patients that will benefit from new or improved drugs. We’ve partnered with WKH&L Research Foundation to give patients access to clinical trials for a variety of indications. Physicians and providers at Med Center Health can use this page to explore research options, download detailed study information, and refer patients into clinical trials.
ADHD (child and adolescent, ages 6 – 17)
Atopic Dermatitis (ages 2+)
COPD (adjunctive therapy, ages 40+)
T2DM (ecently diagnosed, ages 18+)
T2DM (oral medication, ages 18+)
Migraines (pediatric, ages 6 – 17)
Obesity (with CV risk, ages 40+)
ADHD (child and adolescent, ages 6-17)
ADHD (child and adolescent) – Non-Stimulant Medication
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Efficacy and Safety of Once Daily Centanafadine Capsules for the Treatment of Children With Attention-deficit/Hyperactivity Disorder With a rollover option for patients that complete one of the parent studies. A Phase 3, Multicenter, Open-label, Long-term (52 weeks) Trial Evaluating the Long-term Safety and Tolerability of Once Daily Centanafadine Capsules in Children and Adolescents with Attention-deficit/Hyperactivity Disorder.
Refer a Patient/Request a Consult